Blue Jet Healthcare soars on commissioning multi- product Production block at Ambernath Unit 2 facility

01 Jul 2024 Evaluate

Blue Jet Healthcare is currently trading at Rs. 413.95, up by 10.00 points or 2.48% from its previous closing of Rs. 403.95 on the BSE.

The scrip opened at Rs. 400.05 and has touched a high and low of Rs. 425.00 and Rs. 400.05 respectively. So far 9565 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 438.00 on 21-Jun-2024 and a 52 week low of Rs. 319.40 on 12-Dec-2023.

Last one week high and low of the scrip stood at Rs. 425.00 and Rs. 394.40 respectively. The current market cap of the company is Rs. 7218.76 crore.

The promoters holding in the company stood at 86.00%, while Institutions and Non-Institutions held 5.04% and 8.96% respectively.

Blue Jet Healthcare has successfully completed commissioning of multi- product Production block to manufacture pharma intermediates at its existing Unit 2 facility situated at Ambernath, Maharashtra, India. The company has commenced manufacturing of Validation Batches with effect from June 29, 2024. The current capacity utilization is around 70% of the existing capacity. The company is proposed to commercialize full scale production within next six months. Total investment incurred is Rs 90 crore.

The Mumbai-based Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredient and intermediate company, offering niche products targeted towards innovator pharmaceutical companies and multinational generic pharmaceutical companies.


Blue Jet Healthcare Share Price

545.00 -10.40 (-1.87%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×